PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

Arteriovenous Graft Thrombosis Clinical Trial

Official title:
Retrospective Post-Market Clinical Follow Up of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft for Dialysis Access (Artificial Bypass)

Status Completed

Clinical Trial Summary

Retrospective Post-Market Clinical Follow Up of Rotarex®S & Aspirex®S Catheters in treating thrombotic occlusion of Arteriovenous Graft for dialysis access (Artificial Bypass)

Clinical Trial Description

To evaluate the safety, technical performance, and clinical efficacy of the Rotarex®S & Aspirex®S Catheters as a stand-alone and adjunctive therapy for the treatment of acute thrombotic occlusion of arteriovenous graft for dialysis access (Artificial Bypass) in accordance with Rotarex®S & Aspirex®S Catheters intended use. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05071872
Study type	Observational
Source	Straub Medical AG
Contact
Status	Completed
Phase
Start date	October 6, 2021
Completion date	June 8, 2022

View Details

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT04494035` - AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System	N/A
	Completed	`NCT03839264` - Optimal Screening Program in Detecting Stenosis and Predicting Thrombosis in Hemodialysis Graft